Free COVID–19 Testing Act

H.R. 748 - CARES Act -Courtney - COVID-19 coverage H.R. 3630 - No Surprises Act - Pallone - surprise medical billing H.R. 3784 - Air Ambulance Affordability Act of 2019 - Neguse - air ambulances H.R. 4223 - Protecting Patients from Surprise Medical Bills Act - Spano - surprise medical billing H.R. 5121 - Healthcare Cost Transparency Act - Beyer - provider price comparison tool H.R. 5239 - Prescription Drug Price Reporting Act - Joyce - reporting on drug expenditures and price changes under group health plans H.R. 5575 - Primary and Behavioral Health Care Access Act of 2020 -Underwood - coverage of primary care and behavioral health visits H.R. 6005 - Know the Price Act - Malinowski - health plan transparency H.R. 6173 - Covering Coronavirus Test Act of 2020 - DeGette - COVID-19 testing coverage H.R. 6193 - Medication Access in Emergencies Act of 2020 - Pappas - coverage of prescription drugs during emergency periods H.R. 6201 - Families First Coronavirus Response Act - Lowey - includes several provisions related to COVID-19 testing coverage H.R. 6213 - No Cost for COVID-19 Testing Act - Wilson - COVID-19 testing coverage H.R. 6214 - To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program - Kind - Medicare Advantage coverage of COVID-19 related visits and testing H.R. 6222 - Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Schakowsky - coverage of certain new preventative services related to COVID-19 H.R. 6231 - Ensuring Access to COVID-19 Preventive Care Act of 2020 - Bucshon - coverage of certain vaccines and testing services during the COVID-19 emergency H.R. 6299 - Rapid Coverage of COVID-19 Vaccine Act of 2020 - Courtney - COVID-19 coverage H.R. 6317 - To provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes - Doggett - special enrollment periods in public health emergency H.R. 6338 - To waive high deductible health plan requirements for health savings accounts -Budd - HDHP coverage during COVID H.R. 6486 - Care for COVID-19 Act 2.0 -Ruiz - COVID H.R. 6514 - Worker Health Coverage Protection Act - Scott - COVID H.R. 6518 - Stop Health Premium Spikes Act of 2020 - Peters - risk corridors H.R. 6532 - COVID Special Enrollment Act of 2020 - Doggett - COVID H.R. 6568 - Coverage for COVID-19 Treatment Act of 2020 - Rochester - COVID H.R. 6644 - To require group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for services furnished via telehealth if such services would be covered if furnished in-person during the COVID-19 emergency. -Schrier - COVID H.R. 6674 - Medicare Crisis Program Act of 2020 -Jayapal - COVID H.R. 6712 - American Healthshare Plans Act of 2020 - Curtis - health share pools H.R. 6810 - Health Care Protection Act -Davis - COVID H.R. 7006 - Improving Care in Home Health Agencies Act - Velazquez - home health services H.R. 7267 - To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to prohibit a group health plan and a health insurance issuer offering group or individual health insurance coverage from reducing contracted rates, or terminating contracts, with health care providers during a public health emergency. - Porter - ERISA S. 1531 - STOP Surprise Medical Bills Act - Cassidy-Bennet - surprise medical billing S. 1948 - Chronic Disease Management Act - Thune - pre-deductible coverage of chronic disease prevention services S. 2546 - Safe Step Act - Murkowski - Step therapy exceptions S. 3200 - Chronic Disease Management Act of 2020 - Thune - coverage of chronic disease prevention services S. 3383 - Continuing Coverage for Preexisting Conditions Act of 2020 -Kennedy - preexisting conditions S. 3499 - A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Smith - COVID-19 cost -sharing S. 3505 - A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Jones - rapid COVID-19 coverage S. 3536 - A bill to provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes - Casey - COVID-19 coverage S. 3610 - American Healthshare Plans Act of 2020 - Paul - health share pools S. 3631 - Relief for Rural Providers During Emergencies Act - Sasse - COVID S. 3741 - Health Care at Home Act of 2020 - Smith - COVID S. 3792 - Tele-Mental Health Improvement Act - Smith - parity S. 3821 - Affordable Health Care Options Act of 2020 - Loeffler - affordability S. 3991 - Coronavirus 2019 Special Enrollment Period Act - Duckworth - SEP S. 4106 - A bill to amend the Public Health Service Act to provide for hospital and insurer price transparency - Braun - price transparency Regulatory Issues: Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to COBRA continuation coverage; issues related to behavioral health benefits; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to COVID-19; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; issues relating to Medicaid best price; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; prior authorization; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

Client expense: $2,250,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office

H.R. 267, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act of 2019; H.R. 535, PFAS Action Act of 2019; H.R. 748, CARES Act; H.R. 1152, A bill to require the Administrator of the Environmental Protection Agency to revise certain ethylene oxide emissions standards under the Clean Air Act, and for other purposes; H.R. 1159 IMAGINE Act; H.R. 1567, Prompt and Fast Action to Stop Damages Act of 2019; H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019; H.R. 1863, A bill to require the Secretary of Defense to determine potential exposure to perfluoroalkyl and polyfluoroalkyl substances, and for other purposes; H.R. 1976, PFAS Detection Act of 2019; H.R. 2051, Sustainable Chemistry Research and Development Act of 2019; H.R. 2102, A bill to amend title 38, United States Code, to furnish hospital care and medical services to veterans, members of the reserve components of the Armed Forces, and dependents who were stationed at military installations at which they were exposed to perfluorooctanoic acid or other per; and polyfluoroalkyl substances, to provide for a presumption of service connection for those veterans and members of the reserve components, and for other purposes; H.R. 2195, PFAS Registry Act of 2019; H.R. 2377, Protect Drinking Water from PFAS Act; H.R. 2500, National Defense Authorization Act for Fiscal Year 2020; H.R. 2533, A bill to assist community water systems affected by PFAS contamination, and for other purposes; H.R. 2566, A bill to require the Administrator of the Environmental Protection Agency to revise the Safer Choice Standard to provide for a Safer Choice Standard to provide for a Safer Choice label for pots, pans, and cooking utensils that do not contain PFAS, and for other purposes; H.R. 2570, PFAS User Fee Act; H.R. 2577, PFAS Right-To-Know Act; H.R. 2591, A bill to prohibit the waste incineration of per-and polyfluoroalkyl substances, and for other purposes; H.R. 2596, protecting communities from New PFAS Act; H.R. 2600, Toxic PFAS Control Act; H.R. 2605, Prevent Release of Toxics Emissions, Contamination, and Transfer Act of 2019; H.R. 2608, PFAS Testing Act; H.R. 2626, PFAS Accountability Act; H.R. 2638, A bill to direct the Administrator of the Environmental Protection Agency to issue guidance on minimizing the use of firefighting foam containing PFAS, and for other purposes; H.R. 2647, SOFFA; H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 2800, PFAS Monitoring Act; H.R. 2827, Keep Food Containers Safe from PFAS Act; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3616, Clean Water Standards for PFAS Act of 2019; H.R. 4088, Superfund Reinvestment Act; H.R. 4295, Protect Our Military Children Act; H.R. 4636, Partnering and Leveraging Assistance to Stop Trash for International Cleaner Seas Act; H.R. 4687, SMART Infrastructure Act; H.R. 5115, RECOVER Act; H.R. 5544, American Innovation and Manufacturing Act of 2019; H.R. 5845, Break Free From Plastic Pollution Act of 2020; H.R. 5906, Recycling Enhancements to Collection and Yield through Consumer Learning and Education (RECYCLE) Act of 2020; H.R. 6160, To extend the chemical facility anti-terrorism standards program of the Department of Homeland Security; H.R. 6201, Families First Coronavirus Response Act; H.R. 6395, William M. Thornberry National Defense Authorization Act for FY 2021; H.R. 7228; Plastic Waste Reduction and Recycling Act; H.R. 7528; To limit the civil liability of persons for the spread or possible transmission of SARS-COV-2 caused by an act or omission while acting in good faith during the COVID-19 emergency period, and for other purposes; S. 403, IMAGINE Act; S. 458, A bill to require the Administrator of the Environmental Protection Agency to revise certain ethylene oxide emissions standards under the Clean Air Act, and for other purposes; S. 483, Pesticide Registration Improvement Act; S. 638, PFAS Action Act of 2019; S. 675, Prompt and Fast Action to Stop Damages Act of 2019; S. 717, Alan Reinstein Ban Asbestos Now Act of 2019; S. 766, PROTECT Asbestos Victims Act of 2019; S. 858, Protecting Military Firefighters from PFAS Act; S. 950, PFAS Detection Act of 2019; S. 999, Sustainable Chemistry Research and Development Act of 2019; S. 1023, A bill to amend title 38, United States Code, to furnish hospital care and medical services to veterans, members of the reserve components of the Armed Forces, and dependents who were stationed at military installations at which they were exposed to perfluorooctanoic acid or other per; and polyfluoroalkyl substances, to provide for a presumption of service connection for those veterans and members of the reserve components, and for other purposes; S. 1038, A bill to strengthen highway funding in the near term, to offer States additional financing tools, and for other purposes; S. 1105, PFAS Registry Act of 2019; S. 1215, National Defense Authorization Act for FY2020; S. 1251, Safe Drinking Water Assistance Act of 2019; S. 1341, SOFFA; S. 1372, PFAS Accountability Act; S. 1473, Protect drinking water from PFAS Act of 2019; S. 1507, PFAS Release Disclosure Act; S. 1534, A bill to require the Secretary of Defense to conduct an assessment of quantum computing technology to address problems associated with exposure to PFAS, and for other purposes; S. 1790, National Defense Authorization Act for FY2020; S. 2353, Protecting Firefighters from Adverse Substances Act of 2019; S. 2754, American Innovation and Manufacturing Act of 2019; S. 2941, Recycling Enhancements to Collection and Yield through Consumer Learning and Education (RECYCLE) Act of 2020; S. 3263, Break Free From Plastic Pollution Act of 2020; S. 3480, PFAS Testing and Treatment Act of 2020; S. 3415, Paid Sick Days for Public Health Emergencies and Personal Family Care Act; S. 3475, COVID-19 Health CARE Worker Protection Act of 2020; S. 3499, Free COVID-19 Testing Act; S. 3506, Chemical Facility Anti-Terrorism Standards Program Extension Act of 2020; S. 3548, CARES Act; S. 4049, National Defense Authorization Act for FY 2021; FY2021 House Interior Appropriations bill; FY2021 Appropriations of House efforts to address congressional plastics use, bans, alternatives and advanced recycling efforts; Unintroduced recycling infrastructure legislation; Unintroduced Plastics Ban Bill; Alternative Fuel Tax Assessment; Antimicrobials; Bisphenol-A; Building and Construction water infrastructure; Chemical Assessment; Chemical Deselection Policies; Chemical Industry as critical infrastructure; Chemical Safety Board; Chemistry Caucus; Chlorinated Paraffins; Chlorine; Corona virus agency response; Covid-19 Stimulus; CPSC, including Phthalates, Flame Retardants, Nominations, and CHAP; Design for the Environment; Energy Recovery; Enforcement guidance during COVID-19; EPA Nominations; FDA product registrations during COVID-19; Flame Retardants; Fluorotechnology including PFOA/PFOS/PFAS; Formaldehyde; Hexavalent Chromium; Infrastructure Procurement Policy and Innovative Materials; Integrated Risk Information System; International Agency for Research of Cancer, including Report on Carcinogens; Labeling and Packaging, including GMOs; Lautenberg Chemical Safety Act Implementation (LCSA) and regulations; Mass balance certification; Microbeads; Microplastics; Nanotechnology; National Environmental Policy Act; NIOSH studies; OSHA (Chemical Concentrations, Process Safety); Permitting Reform, PFAS, including EPA Action Plan; Phthalates; Plastics, including Plastics Recycling; Portland Cement Associations NHSM Petition; Risk Assessment Improvements; Science Advisory Board; Sustainability including report on innovation and Research and Development; Sustainable Municipal Access to Resilient Technology in Infrastructure Act; Styrene; T-TIP, MTB and Trade Promotion Authority; Titanium Dioxide

Issues related to Covid-19 Emergency Response H.R. 6312 S. 3499

Client expense: Not reported · Firm income: Not reported

H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 1093: Stop Price Gouging Act - Provisions related to prescription drug pricing H.R. 1323: Rural Hospital Frontier Fairness Act - Provisions related to the 340B drug discount program H.R. 2296: FAIR Drug Pricing Act of 2019 / More Efficient Tools to Realize Information for Consumers Act - Provisions related to prescription drug pricing and transparency H.R. 2376: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers H.R. 4812: Ensuring Compliance Against Drug Diversion Act of 2019 - Provisions related to registrations under the Controlled Substances Act H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6019: Cure the Coronavirus Act - Provisions related to FDA prescription drug approvals H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6173: Covering Coronavirus Test Act of 2020 - Provisions related to medical device pricing and coverage H.R. 6213: No Cost for COVID-19 Testing Act - Provisions related to medical device pricing and coverage H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6253: To expand certain securities exemptions to respond to COVID-19, to establish an X-prize for creating an effective COVID-19 vaccine, and for other purposes - Provisions related to prescription drug research and development H.R. 6261: To provide for coverage of testing for COVID-19 at no cost sharing for Indians receiving health services through the Indian Health Service, and for other purposes - Provisions related to medical device pricing and coverage H.R. 6264: To prohibit price gouging during a state of emergency declaration, and for other purposes - Provisions related to prescription drug and medical device pricing H.R. 6351: To authorize the Secretary of Health and Human Services to administer vaccinations for COVID-19, once available, at no cost to the inoculated, in response to the COVID-19 outbreak, and for other purposes - Provisions related to prescription drug patient access and cost sharing H.R. 6390: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 474: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019 - Provisions related to increases in the wholesale acquisition costs of prescription drugs S. 637: Combatting Unreasonable Rises and Excessively (CURE) High Drug Prices Act - Provisions related to prescription drug pricing and transparency S. 657: Drug Price Transparency Act - Provisions related to prescription drug pricing transparency and commercial market rebates S. 660: Efficiency and Transparency in Petitions Act - Provisions related to the FDA citizen petition process S. 801: Payment Commission Data Act of 2019 - Provisions related to prescription drug pricing transparency S. 977: Transparent Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and foreign reference pricing S. 1089: Restoring Access to Medication Act of 2019 - Provisions related to prescription drug access S. 1227: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1567: Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2019 - Provisions related to rare disease research and funding S1872/HR5076 Protecting Seniors Through Immunization Act S. 1897: A bill to establish a process for updating the labeling of certain drugs with outdated labeling - Provisions related to prescription drug labeling S. 2004: Emergency Access to Insulin Act of 2019 - Provisions related to prescription drug pricing S. 2103: Affordable Insulin Approvals Now Act - Provisions related to FDA prescription drug approvals S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 2897: Patient-Centered Outcomes Research Institute Reauthorization Act - Provisions related to PCORI reauthorization S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3180: Responsibility in Drug Advertising Act of 2020 - Provisions related to prescription drug direct-to-consumer advertising S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3432: Securing America's Medicine Cabinet Act of 2020 - Provisions related to advanced manufacturing and prescription drugs S. 3442: Care for COVID-19 Act - Provisions related to prescription drug pricing and access S. 3499: A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Provisions related to medical device pricing and access S. 3505: A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Provisions related to prescription drug pricing and access S. 3545: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes - Provisions related to FDA prescription drug marketing approvals S. 3564: A bill to amend title XIX of the Social Security Act to require States to provide medical assistance for COVID-19 treatment services for individuals who are diagnosed with COVID-19, and for other purposes - Provisions related to prescription drug pricing and access S. 3570: A bill to provide for the expedited procurement of equipment needed to combat COVID-19 under the Defense Production Act of 1950 - Provisions related to the Defense Production Act Transparency policy issues Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Expanded access policy issues Antimicrobial resistance policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues Monograph Reform CDC Programmatic Funding Restoration of HSA/FSAs 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Cancer drug vial size policy issues Drug shortages policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients

H.R. 748 - CARES Act -Courtney - COVID-19 coverage H.R. 3630 - No Surprises Act - Pallone - surprise medical billing H.R. 3784 - Air Ambulance Affordability Act of 2019 - Neguse - air ambulances H.R. 4223, Protecting Patients from Surprise Medical Bills Act - Spano - surprise medical billing H.R. 5121 - Healthcare Cost Transparency Act - Beyer - provider price comparison tool H.R. 5239 - Prescription Drug Price Reporting Act - Joyce - reporting on drug expenditures and price changes under group health plans H.R. 5575 - Primary and Behavioral Health Care Access Act of 2020 -Underwood - coverage of primary care and behavioral health visits H.R. 6005 - Know the Price Act - Malinowski - health plan transparency H.R. 6173 - Covering Coronavirus Test Act of 2020 - DeGette - COVID-19 testing coverage H.R. 6193 - Medication Access in Emergencies Act of 2020 - Pappas - coverage of prescription drugs during emergency periods H.R. 6201 - Families First Coronavirus Response Act - Lowey - includes several provisions related to COVID-19 testing coverage H.R. 6213 - No Cost for COVID-19 Testing Act - Wilson - COVID-19 testing coverage H.R. 6214 - To amend title XVIII of the Social Security Act to provide for coverage of testing for COVID-19 at no cost sharing under the Medicare Advantage program - Kind - Medicare Advantage coverage of COVID-19 related visits and testing H.R. 6222 - Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Schakowsky - coverage of certain new preventative services related to COVID-19 H.R. 6231 - Ensuring Access to COVID-19 Preventive Care Act of 2020 - Bucshon - coverage of certain vaccines and testing services during the COVID-19 emergency H.R. 6299 - Rapid Coverage of COVID-19 Vaccine Act of 2020 - Courtney - COVID-19 coverage H.R. 6317 - To provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes - Doggett - special enrollment periods in public health emergency H.R. 6338 - To waive high deductible health plan requirements for health savings accounts -Budd - HDHP coverage during COVID S. 1531 - STOP Surprise Medical Bills Act - Cassidy-Bennet - surprise medical billing S. 1948 - Chronic Disease Management Act - Thune - pre-deductible coverage of chronic disease prevention services S. 2546 - Safe Step Act - Murkowski - Step therapy exceptions S. 3200 - Chronic Disease Management Act of 2020 - Thune - coverage of chronic disease prevention services S. 3383 - Continuing Coverage for Preexisting Conditions Act of 2020 -Kennedy - preexisting conditions S. 3499 - A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Smith - COVID-19 cost -sharing S. 3505 - A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Jones - rapid COVID-19 coverage S. 3536 - A bill to provide for special enrollment periods during public health emergencies, coverage of services related to public health emergencies, and for other purposes - Casey - COVID-19 coverage Regulatory Issues: Insurance regulatory reform; issues related to the coordination of private and public disability income benefits; disability risk management; disability income insurance enrollment and awareness; issues related to encouraging impaired workers to stay in/return to the workforce; issues related to expanding long-term care insurance coverage; issues relating to COVID-19; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; issues relating to the coordination of benefits between private health insurance plans and Medicaid; Medigap claims processing and crossover fees; Medigap cross-over claim issues, Medigap coverage, implementation of Medigap standardized plan offerings; Medigap carrier recoveries related to CMS fraud and abuse enforcement activities, and issues related to Medigap educational materials, and other Medigap issues; fraud and abuse issues affecting public and private insurance coverage; issues relating to antitrust; implementation of the Mental Health Parity Act requirements; implementation of the 21st Century Cures Act requirements; summary of benefits and coverage disclosures; prior authorization; accountable care organizations; coverage of preventive services; preexisting condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; health reimbursement accounts; dependent coverage; treatment of expatriate plans; issues related to surprise medical bills; issues related to all payor claims databases; issues related to association health plans; issues related to substance abuse and provider treatment records (42 CFR Part 2); issues related to medical management; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations, non-discriminatory wellness programs; issues related to supplemental products; issues relating to dental coverage; issues relating to proposals for single-payer and Medicare/Medicaid buy-in options; issues related to implementation of the Telephone Consumer Protection Act; issues relating to third party payment of premiums; issues related to cost-sharing reductions (CSRs); issues related to interoperability and price transparency; issues related to the employer market; issues relating to the individual market; and other issues relating to health care reform implementation.

H.R. 267, Transportation, Housing and Urban Development, and Related Agencies Appropriations Act of 2019; H.R. 535, PFAS Action Act of 2019; H.R. 748, CARES Act; H.R. 1152, A bill to require the Administrator of the Environmental Protection Agency to revise certain ethylene oxide emissions standards under the Clean Air Act, and for other purposes; H.R. 1159 IMAGINE Act; H.R. 1567, Prompt and Fast Action to Stop Damages Act of 2019; H.R. 1603, Alan Reinstein Ban Asbestos Now Act of 2019; H.R. 1863, A bill to require the Secretary of Defense to determine potential exposure to perfluoroalkyl and polyfluoroalkyl substances, and for other purposes; H.R. 1976, PFAS Detection Act of 2019; H.R. 2051, Sustainable Chemistry Research and Development Act of 2019; H.R. 2102, A bill to amend title 38, United States Code, to furnish hospital care and medical services to veterans, members of the reserve components of the Armed Forces, and dependents who were stationed at military installations at which they were exposed to perfluorooctanoic acid or other per; and polyfluoroalkyl substances, to provide for a presumption of service connection for those veterans and members of the reserve components, and for other purposes; H.R. 2195, PFAS Registry Act of 2019; H.R. 2377, Protect Drinking Water from PFAS Act; H.R. 2500, National Defense Authorization Act for Fiscal Year 2020; H.R. 2533, A bill to assist community water systems affected by PFAS contamination, and for other purposes; H.R. 2566, A bill to require the Administrator of the Environmental Protection Agency to revise the Safer Choice Standard to provide for a Safer Choice Standard to provide for a Safer Choice label for pots, pans, and cooking utensils that do not contain PFAS, and for other purposes; H.R. 2570, PFAS User Fee Act; H.R. 2577, PFAS Right-To-Know Act; H.R. 2591, A bill to prohibit the waste incineration of per-and polyfluoroalkyl substances, and for other purposes; H.R. 2596, protecting communities from New PFAS Act; H.R. 2600, Toxic PFAS Control Act; H.R. 2605, Prevent Release of Toxics Emissions, Contamination, and Transfer Act of 2019; H.R. 2608, PFAS Testing Act; H.R. 2626, PFAS Accountability Act; H.R. 2638, A bill to direct the Administrator of the Environmental Protection Agency to issue guidance on minimizing the use of firefighting foam containing PFAS, and for other purposes; H.R. 2647, SOFFA H.R. 2740, Labor, Health and Human Services, Education, Defense, State, Foreign Operations, and Energy and Water Development Appropriations Act, 2020; H.R. 2800, PFAS Monitoring Act; H.R. 2827, Keep Food Containers Safe from PFAS Act; H.R. 3055, Commerce, Justice, Science, Agriculture, Rural Development, Food and Drug Administration, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2020; H.R. 3616, Clean Water Standards for PFAS Act of 2019; H.R. 4088, Superfund Reinvestment Act; H.R. 4295, Protect Our Military Children Act; H.R. 4636, Partnering and Leveraging Assistance to Stop Trash for International Cleaner Seas Act; H.R. 4687, SMART Infrastructure Act; H.R. 5115, RECOVER Act; H.R. 5544, American Innovation and Manufacturing Act of 2019; H.R. 5845, Break Free From Plastic Pollution Act of 2020; H.R. 5906, Recycling Enhancements to Collection and Yield through Consumer Learning and Education (RECYCLE) Act of 2020; H.R. 6160, To extend the chemical facility anti-terrorism standards program of the Department of Homeland Security; H.R. 6201, Families Fist Coronavirus Response Act; S. 403, IMAGINE Act; S. 458, A bill to require the Administrator of the Environmental Protection Agency to revise certain ethylene oxide emissions standards under the Clean Air Act, and for other purposes; S. 483, Pesticide Registration Improvement Act; S. 638, PFAS Action Act of 2019; S. 675, Prompt and Fast Action to Stop Damages Act of 2019; S. 717, Alan Reinstein Ban Asbestos Now Act of 2019; S. 766, PROTECT Asbestos Victims Act of 2019; S. 858, Protecting Military Firefighters from PFAS Act; S. 950, PFAS Detection Act of 2019; S. 999, Sustainable Chemistry Research and Development Act of 2019; S. 1023, A bill to amend title 38, United States Code, to furnish hospital care and medical services to veterans, members of the reserve components of the Armed Forces, and dependents who were stationed at military installations at which they were exposed to perfluorooctanoic acid or other per; and polyfluoroalkyl substances, to provide for a presumption of service connection for those veterans and members of the reserve components, and for other purposes; S. 1038, A bill to strengthen highway funding in the near term, to offer States additional financing tools, and for other purposes; S. 1105, PFAS Registry Act of 2019; S. 1215, National Defense Authorization Act for FY2020; S. 1251, Safe Drinking Water Assistance Act of 2019; S. 1341, SOFFA; S. 1372, PFAS Accountability Act; S. 1473, Protect drinking water from PFAS Act of 2019; S. 1507, PFAS Release Disclosure Act; S. 1534, A bill to require the Secretary of Defense to conduct an assessment of quantum computing technology to address problems associated with exposure to PFAS, and for other purposes; S. 1790, National Defense Authorization Act for FY2020; S. 2353, Protecting Firefighters from Adverse Substances Act of 2019; S. 2754, American Innovation and Manufacturing Act of 2019; S. 2941, Recycling Enhancements to Collection and Yield through Consumer Learning and Education (RECYCLE) Act of 2020; S. 3263, Break Free From Plastic Pollution Act of 2020; S. 3480, PFAS Testing and Treatment Act of 2020; S. 3415, Paid Sick Days for Public Health Emergencies and Personal Family Care Act; S. 3475, COVID-19 Health CARE Worker Protection Act of 2020; S. 3499, Free COVID-19 Testing Act; S. 3506, Chemical Facility Anti-Terrorism Standards Program Extension Act of 2020; S. 3548, CARES Act; FY2019 Appropriations of Department of the Interior, environment, and related agencies; FY2019 Appropriations of Department of Labor, Health and Human Services; FY2021 Appropriations of House efforts to address congressional plastics use, bans, alternatives and advanced recycling efforts; Unintroduced recycling infrastructure legislation; Unintroduced Plastics Ban Bill; Alternative Fuel Tax Assessment; Antimicrobials; Bisphenol-A; Building and Construction water infrastructure; Chemical Assessment; Chemical Deselection Policies; Chemical Industry as critical infrastructure; Chemical Safety Board; Chemistry Caucus; Chlorinated Paraffins; Chlorine; Corona virus agency response; CPSC, including Phthalates, Flame Retardants, Nominations, and CHAP; Design for the Environment; Energy Recovery; EPA Nominations; Flame Retardants; Fluorotechnology including PFOA/PFOS/PFAS; Formaldehyde; Hexavalent Chromium; Infrastructure Procurement Policy and Innovative Materials; Integrated Risk Information System; International Agency for Research of Cancer, including Report on Carcinogens; Labeling and Packaging, including GMOs; Lautenberg Chemical Safety Act Implementation (LCSA) and regulations; Microbeads; Microplastics; Nanotechnology; National Environmental Policy Act; NIOSH studies; OSHA (Chemical Concentrations, Process Safety); Permitting Reform, PFAS, including EPA Action Plan; Phthalates; Plastics, including Plastics Recycling; Portland Cement Associations NHSM Petition; Risk Assessment Improvements; Science Advisory Board; Sustainability including report on innovation and Research and Development; Sustainable Municipal Access to Resilient Technology in Infrastructure Act; Styrene; T-TIP, MTB and Trade Promotion Authority; Titanium Dioxide

H.R. 965: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 985: FAST Generics Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems H.R. 1093: Stop Price Gouging Act - Provisions related to prescription drug pricing H.R. 1323: Rural Hospital Frontier Fairness Act - Provisions related to the 340B drug discount program H.R. 2296: FAIR Drug Pricing Act of 2019 / More Efficient Tools to Realize Information for Consumers Act - Provisions related to prescription drug pricing and transparency H.R. 2376: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers H.R. 4812: Ensuring Compliance Against Drug Diversion Act of 2019 - Provisions related to registrations under the Controlled Substances Act H.R. 5239: Prescription Drug Price Reporting Act - Provisions related to prescription drug pricing transparency H.R. 5382: To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices. - Provisions related to prescription drug pricing H.R. 5668: MODERN Labeling Act of 2020 - Provisions related to prescription drug labeling H.R. 6019: Cure the Coronavirus Act - Provisions related to FDA prescription drug approvals H.R. 6080: Preventing Drug Shortages Act - Provisions related to prescription drug shortage reporting requirements H.R. 6173: Covering Coronavirus Test Act of 2020 - Provisions related to medical device pricing and coverage H.R. 6213: No Cost for COVID-19 Testing Act - Provisions related to medical device pricing and coverage H.R. 6222: Ensuring Affordable COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6231: Ensuring Access to COVID-19 Preventive Care Act of 2020 - Provisions related to prescription drug pricing and access H.R. 6253: To expand certain securities exemptions to respond to COVID-19, to establish an X-prize for creating an effective COVID-19 vaccine, and for other purposes - Provisions related to prescription drug research and development H.R. 6261: To provide for coverage of testing for COVID-19 at no cost sharing for Indians receiving health services through the Indian Health Service, and for other purposes - Provisions related to medical device pricing and coverage H.R. 6264: To prohibit price gouging during a state of emergency declaration, and for other purposes - Provisions related to prescription drug and medical device pricing H.R. 6351: To authorize the Secretary of Health and Human Services to administer vaccinations for COVID-19, once available, at no cost to the inoculated, in response to the COVID-19 outbreak, and for other purposes - Provisions related to prescription drug patient access and cost sharing H.R. 6390: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act H.R. 6410: To direct the President to use authority under the Defense Production Act of 1950 to ensure an adequate supply equipment necessary for limiting the spread of COVID-19 - Provisions related to the Defense Production Act S. 61: Safe and Affordable Drugs from Canada Act of 2019 - Provisions related to importation S. 73: End Taxpayer Subsidies for Drug Ads Act - Provisions related to direct-to-consumer prescription drug advertising S. 340: Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019 - Provisions related to Risk Evaluation and Mitigation Strategies (REMS) and limited distribution systems S. 474: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2019 - Provisions related to increases in the wholesale acquisition costs of prescription drugs S. 637: Combatting Unreasonable Rises and Excessively (CURE) High Drug Prices Act - Provisions related to prescription drug pricing and transparency S. 657: Drug Price Transparency Act - Provisions related to prescription drug pricing transparency and commercial market rebates S. 660: Efficiency and Transparency in Petitions Act - Provisions related to the FDA citizen petition process S. 801: Payment Commission Data Act of 2019 - Provisions related to prescription drug pricing transparency S. 977: Transparent Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and foreign reference pricing S. 1089: Restoring Access to Medication Act of 2019 - Provisions related to prescription drug access S. 1227: Prescription Pricing for the People Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1384: Prescription Drug Rebate Reform Act of 2019 - Provisions related to prescription drug pricing and negotiated rebates S. 1391: FAIR Drug Pricing Act of 2019 - Provisions related to prescription drug pricing and transparency S. 1437: Drug-price Transparency in Communications (DTC) Act - Provisions related to direct-to-consumer prescription drug advertising S. 1532: Pharmacy Benefit Manager Accountability Study Act of 2019 - Provisions related to prescription drug pricing transparency and pharmacy benefit managers S. 1567: Finding Orphan-disease Remedies With Antifungal Research and Development Act of 2019 - Provisions related to rare disease research and funding S. 1897: A bill to establish a process for updating the labeling of certain drugs with outdated labeling - Provisions related to prescription drug labeling S. 2004: Emergency Access to Insulin Act of 2019 - Provisions related to prescription drug pricing S. 2103: Affordable Insulin Approvals Now Act - Provisions related to FDA prescription drug approvals S. 2161: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2019 - Provisions related to reciprocity S. 2304: Strategies To Address Antibiotic Resistance Act - Provisions related to antimicrobial resistance (AMR) and other issues S. 2723: Mitigating Emergency Drug Shortages Act - Provisions related to prescription drug pricing transparency and other provisions S. 2897: Patient-Centered Outcomes Research Institute Reauthorization Act - Provisions related to PCORI reauthorization S. 3162: Affordable Drug Manufacturing Act of 2019 - Provisions related to prescription drug manufacturing S. 3166: Prescription Drug Affordability and Access Act - Provisions related to prescription drug pricing S. 3180: Responsibility in Drug Advertising Act of 2020 - Provisions related to prescription drug direct-to-consumer advertising S. 3384: Lowering Prescription Drug Prices for America's Seniors and Families Act of 2020 - Provisions related to prescription drug price negotiation, importation, and other issues S. 3439: Lower Health Insurance Deductibles Act - Provisions related to prescription drug pricing and insurance plan design S. 3432: Securing America's Medicine Cabinet Act of 2020 - Provisions related to advanced manufacturing and prescription drugs S. 3442: Care for COVID-19 Act - Provisions related to prescription drug pricing and access S. 3468 Preventing Essential Medical Device Shortages Act of 2020 - Provisions related to medical device shortage reporting requirements S. 3499: A bill to amend coverage requirements to ensure that no person incurs cost sharing when receiving a test to confirm a COVID-19 infection - Provisions related to medical device pricing and access S. 3505: A bill to require private health insurance to rapidly cover preventive services and vaccines related to the coronavirus - Provisions related to prescription drug pricing and access S. 3545: A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for reciprocal marketing approval of certain drugs, biological products, and devices that are authorized to be lawfully marketed abroad, and for other purposes - Provisions related to FDA prescription drug marketing approvals S. 3564: A bill to amend title XIX of the Social Security Act to require States to provide medical assistance for COVID-19 treatment services for individuals who are diagnosed with COVID-19, and for other purposes - Provisions related to prescription drug pricing and access S. 3568: To require the President to use authorities under the Defense Production Act of 1950 to require emergency production of medical equipment to address the COVID-19 outbreak - Provisions related to the Defense Production Act S. 3570: A bill to provide for the expedited procurement of equipment needed to combat COVID-19 under the Defense Production Act of 1950 - Provisions related to the Defense Production Act Transparency policy issues Drug cost and pricing policy issues Drug importation and counterfeiting policy issues HHS Safe Importation Action Plan Prescription drug take back and secure disposal policy issues Policy issues related to prescription drug abuse and opioids Expanded access policy issues Antimicrobial resistance policy issues High deductible health plans/HSA policy issues Sharing of truthful and non-misleading information about medicines with healthcare professionals and payors Risk Evaluation and Mitigation Strategy (REMS) policy issues FDA modernization policy issues PDUFA implementation policy issues 340B drug discount program policy issues Bipartisan Budget Act of 2018 (Public Law 115-123) - Part D provisions Patient assistance program policy issues Foreign manufacturing policy issues Biosimilar approval and reimbursement policy issues Cancer drug vial size policy issues Drug shortages policy issues Proposed Rule; Importation of Prescription Drugs (RIN 0910-AI45) Buy America and other associated issues related to procurement and sourcing of finished product and active pharmaceutical ingredients

Lobbying Issues Description: Budget and appropriations for disease and injury prevention, including obesity and related diseases; pandemic influenza and emerging infectious diseases; physical activity; public health bioterrorism preparedness; food safety, environmental health; paid sick days; womens and childrens health; community-based public health interventions, and substance misuse/behavioral health issues. Specific Legislation: 1. Implementation of the Patient Protection and Affordable Care Act (Public Law 111-148) 2. Implementation of the FDA Food Safety Modernization Act (Public Law 111353) 3. Implementation of Pandemic and All-Hazards Preparedness Reauthorization Act and Pandemic and All-Hazards Preparedness and Advancing Innovation Act (Public Law 113-5, 116-22) 4. Implementation of Healthy, Hunger-Free Kids Act of 2010 (Public Law 111296) 5. Implementation of Child Care and Development Block Grant Act of 2014 (Public Law 113-186) 6. Implementation of Every Student Succeeds Act (Public Law 114-95) 7. Implementation of the Comprehensive Addition and Recovery Act (Public Law 114-98) 8. FY 2020 Departments of Labor, Health and Human Services, and Education and Related Agencies Appropriations (H.R. 2740/Not Yet Introduced)) 9. FY 2020 Departments of Agriculture, Rural Development, Food and Drug Administration and Related Agencies Appropriations (H.R. 3164/Not yet introduced) 10. FY2020 Departments of Transportation, HUD and related agencies Appropriations (H.R. 3163/Not Yet Introduced) 11. FY2020 Further Consolidated Appropriations Act (H.R. 1865/P.L. 116-94) 12. Midnight Rules Relief Act (S.34/H.R. 21) 13. Regulations from the Executive in Need of Scrutiny Act (S. 21/H.R. 26) 14. Regulatory Accountability Act (S.951/H.R. 5/H.R. 45/H.Res.33) 15. Searching for and Cutting Regulations that are Unnecessarily Burdensome (SCRUB) Act (H.R. 998) 16. Regulatory Integrity Act (H.R. 1004) 17. OIRA Insight, Reform, and Accountability Act (S. 676/H.R. 1009) 18. A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026 (S.Con.Res. 3) 19. American Health Care Act (H.R. 1628/H.Res. 228) 20. Ozone Standards Implementation Act (S. 263/H.R. 806) 21. Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the final rule of the Bureau of Land Management relating to "Waste Prevention, Production Subject to Royalties, and Resource Conservation" (S.J. Res. 11/H.J.Res.36) 22. Common Sense Nutrition Disclosure Act (S. 261/H.R. 772) 23. Reinvigorating Antibiotic and Diagnostic Innovation (READI) Act (H.R. 1840) 24. Preservation of Antibiotics for Medical Treatment Act (H.R. 1587) 25. Preventing Antibiotic Resistance Act (S. 629) 26. Better Care Reconciliation Act (H.R. 1628) and related amendments 27. Public Health Emergency Response Act (S. 196) 28. Recognizing the importance of vaccinations and immunizations in the United States (H.Res.327) 29. Consolidated Appropriations Act, 2017 (Public Law 115-31) 30. Treat and Reduce Obesity Act (S. 830/H.R. 1953) 31. Community Health and Medical Professionals Improve Our Nation (CHAMPION) Act (H.R. 3922) 32. Community Health Investment, Modernization, and Excellence Act of 2017 (S. 1899) 33. Tobacco Tax Equity Act (S. 1837) 34. Healthy Kids Act (S. 1821/H.R. 3921) 35. Implementation of the Drug Quality and Security Act (P.S. 113-54) 36. Continuing Appropriations Act, 2018 and Supplemental Appropriations for Disaster Relief Requirements Act, 2017 (Public Law 115-56) 37. Friendly Airports for Mothers Act (S. 1110/H.R. 2375) 38. Lead-Safe Housing for Kids Act (S. 1845) 39. Supporting Working Moms Act (S. 2122/H.R. 3255) 40. Championing Healthy Kids Act (H.R. 3922) 41. Making further continuing appropriations for fiscal year 2018, and for other purposes (Public Law 115-90) 42. An Act to amend the Homeland Security Act of 2002 to require the Secretary of Homeland Security to issue Department of Homeland Security-wide guidance and develop training programs as part of the Department of Homeland Security Blue Campaign, and for other purposes (Public Law 11596) 43. Tax Cuts and Jobs Act (Public Law 115-97) 44. Pandemic and All-Hazards Preparedness Advancing Innovation Act (S. 2852/H.R. 6378/H.R. 7328/S. 1379/H.R. 269) 45. Vaccine Access Improvement Act (H.R. 4993) 46. Relief from New Source Performance Standards Act (H.R. 453) 47. Strategies to Address Antimicrobial Resistance (S. 2469) 48. Opioid Quota Reform Act (S. 2535) 49. Hospital Preparedness Program Reauthorization Act (H.R. 4776) 50. Blocking Regulatory Interference from Closing Kilns Act (H.R. 1917) 51. Opioid Crisis Response Act of 2018 (S. 2680) 52. Agriculture and Nutrition Act (H.R. 2) 53. Agriculture Improvement Act (S. 3042) 54. SECURE Act (H.R. 5998) 55. Trauma-Informed Care for Children and Families Act (S. 774) 56. SUPPORT for Patients and Communities Act (H.R. 6) 57. Centers for Disease Control Emergency Response Act (S. 3161) 58. LABEL Opioids Act (S. 3428) 59. Relief from New Source Performance Standards Act (S. 1857) 60. Outdoors for All Act (S. 3499) 61. The MOMMA Act (H.R. 5977) 62. Preventing Maternal Deaths Act (H.R. 1318) 63. Medicare Access to Vaccines Equity Act (note yet introduced) 64. The Support Act (H.R. 6) 65. Climate Change Health Protection and Promotion Act (S. 529) 66. FY 2020 Departments of the Interior, Environment, and Related Agencies Appropriations Act (H.R. 3052/Not Yet Introduced) 67. NURSE Act (H.R. 1597) 68. Investing for the People Act (H.R. 2021) 69. Child Care for Working Families Act (H.R. 365/S. 568) 70. FAMILY Act (H.R. 1185/S. 463) 71. Transportation Alternatives Enhancement Act (S. 1098) 72. Lower Health Care Costs Act (S. 1895) 73. LIFT America Act (H.R 2479) 74. Public Health Funding Restoration Act (H.R. 3447/S. 1944) 75. Older Americans Act reauthorization (not yet introduced) 76. Campus Prevention and Recovery Services for Students Act (H.R. 3591) 77. Healthier Students for Stronger Campuses Act (S. 1281) 78. Saving Lives Through Better Data Act (S. 1793) 79. VACCINES Act (H.R. 2862) 80. DISARM Act (H.R. 4100/S. 1712) 81. Community Access, Resources, and Education for Families Act (H.R. 3117) 82. Protecting Seniors Through Immunization Act (S. 1872) 83. Tobacco-Free Youth Act (S. 1541) 84. Tobacco to 21 Act (H.R. 2411/S. 1258) 85. Investing for People Act (H.R. 2021) 86. School Based Health Centers Reauthorization Act (H.R.2075/S.1013) 87. Reversing the Youth Tobacco Epidemic Act of 2019 (H.R. 2339) 88. Social Determinants Accelerator Act (H.R. 4004) 89. Mental Health Professionals Workforce Shortage Loan Repayment Act (H.R. 2431) 90. The UNDERSTAND Act (S. 1323) 91. Americas Transportation Infrastructure Act (S. 2302) 92. Health Equity and Accountability Act (Not yet introduced) 93. Barriers to Suicide Act of 2019 (H.R. 4309) 94. Promoting Physical Activity for Americans Act (S. 1608/H.R. 2891) 95. Public Health Infrastructure Modernization Act of 2019 (H.R. 5321) 96. Supporting Healthy Mothers and Infants Act (H.R. 5249) 97. Lead-Free Future Act (H.R. 4416) 98. Home Visiting to Reduce Maternal Mortality and Morbidity Act (H.R. 4768) 99. Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide (H. Res. 592) 100. Coronavirus Preparedness and Response Supplemental Appropriations Act (H.R. 6074) 101. Families First Coronavirus Response Act (H.R. 6201) 102. Coronavirus Aid, Relief, and Economic Security (CARES) Act (H.R. 748) 103. Connecting Americas Transportation Infrastructure Act (S. 2302) 104. Improving Access to Remote Behavioral Health Treatment Act (S. 2244/H.R. 4131) 105. National Suicide Hotline Designation Act (S. 2661/H.R. 4194) 106. Suicide Prevention Lifeline Improvement Act (H.R. 4564) 107. Campaign to Prevent Suicide Act (H.R. 4585) 108. Medicaid Reentry Act (H.R. 1329) 109. Excellence in Mental Health and Addiction Treatment Expansion Act (S. 824/H.R. 1767) 110. Mental Health Services for Students Act (S. 1122/H.R. 1109) 111. Suicide Training and Awareness Nationally Delivered for Universal Prevention (STANDUP) Act (S. 2492/H.R. 2599) 112. Mental Health Parity Compliance Act (S. 1737/H.R. 3165) 113. Behavioral Health Transparency Act (S. 1576/H.R. 2874) 114. Medicare Mental Health Access Act (S. 2772/H.R. 884) 115. Public Health Emergency Response and Accountability Act (S. 3309) 116. Family Violence Prevention and Services Improvement Act (H.R. 5041) House(s) of Congress and Federal Agencies lobbied during the quarter: House, Senate, Exec Office of Pres, HHS, CDC, FDA, CMS, OMB, DOT, HUD, EPA, NIMH, Education, USDA, DHS, FEMA, and SAMHSA